Identifying accurate biomarkers of cognitive decline is essential for advancing early diagnosis and prevention therapies in Alzheimer’s Disease. The Alzheimer’s Disease DREAM Challenge was designed as a computational crowdsourced project to benchmark the current state-of-the-art in predicting cognitive outcomes in Alzheimer’s Disease based on high-dimensional, publicly available genetic and structural imaging data. This meta-analysis failed to identify a meaningful predictor developed from either data modality, suggesting that alternate approaches should be considered for to prediction of cognitive performance.

Abstract.We recently proposed a novel clone-by-clone protocol for de novo genome sequencing that leverages combinatorial pooling design to overcome the limitations of DNA barcoding when multiplexing a large number of samples on second-generation sequencing instruments. Here we address the problem of correcting the short reads obtained from our sequencing protocol. We introduce a novel algorithm called Scrible that exploits properties of the pooling design to accurately identify/correct sequencing errors and minimize the chance of "over-correcting". Experimental results on synthetic data on the rice genome demonstrate that our method has much higher accuracy in correcting short reads compared to state-of-the-art error-correcting methods. On real data on the barley genome we show that Scrible significantly improves the decoding accuracy of short reads to individual BACs.

No abstract

No abstract